Skip to main content
Free information guide · Updated July 2026

Clinical Oncology in the UK for Internationally-Qualified Doctors

A plain-English guide to a UK clinical-oncology career for internationally-qualified doctors — why demand tracks cancer waiting times, the GMC specialist-registration route, and how NHS pay works.

As of July 2026, a doctor who wants to work as a clinical oncologist in the UK — treating cancer with radiotherapy and systemic therapy — must hold registration with a licence to practise from the General Medical Council (GMC), and, for a substantive consultant post, be on the GMC Specialist Register in clinical oncology. The specialty has a large documented shortfall: the Royal College of Radiologists’ clinical oncology workforce census (2022 data, published 2023) reported a UK consultant clinical-oncologist shortfall of around 17%, and projected it could reach roughly 26% by 2027 without action.

Why UK clinical oncology relies on international doctors

Clinical oncologists deliver radiotherapy and non-surgical cancer treatment, so demand for them rises directly with cancer incidence and the pressure on cancer-treatment targets. The Royal College of Radiologists’ clinical oncology workforce census (2022 data, published 2023) reported a UK consultant shortfall of around 17%, projected to widen to roughly 26% by 2027 as demand outpaces training numbers.

That shortfall is one reason NHS trusts that struggle against the 62-day cancer-treatment standard turn to additional and internationally-qualified oncologists. For a doctor with oncology experience overseas, the UK has sustained demand across substantive and career-grade posts.

This page is information for doctors independently considering the move — not a vacancy advert, and Gera is not a recruitment agency. Confirm the current census figures with the Royal College of Radiologists (rcr.ac.uk).

~17% reported UK consultant clinical-oncologist shortfall (projected ~26% by 2027). Source: Royal College of Radiologists clinical oncology workforce census, 2022 data (published 2023).

See where cancer-treatment pressure is greatest — the Gera NHS waiting-times context

How NHS pay works for this specialty

NHS basic pay is set by grade, not by specialty. The figures below are for England, 2024/25 — indicative, and different in Scotland, Wales and Northern Ireland.

GradeTypical roleBasic pay (England)Notes
Foundation Year 1 (FY1)Newly-qualified resident (formerly "junior") doctor, first year£36,616The starting basic salary for a first-year foundation doctor in England. Additional pay applies for out-of-hours and on-call work.
Specialty registrar (StR)Doctor in higher specialty training£55,329 – £70,425Basic pay across the specialty-training nodal points (2016 contract, England). On-call and out-of-hours supplements are added on top.
Specialty doctor (SAS)Non-training career-grade doctor£59,175 – £95,400The 2021 specialty-doctor contract range. A common substantive route for internationally-qualified doctors before or instead of the specialist register.
ConsultantSenior doctor on the GMC Specialist Register£105,504 – £139,882The England consultant pay scale — the same range for every hospital specialty, because basic pay is grade-based, not specialty-based. Requires specialist registration.

A consultant clinical oncologist is paid on the standard England consultant pay scale — the same grade-based scale as every other consultant specialty. Additional job-planned sessions and, for some, private oncology work can affect total earnings, but the basic scale is not specialty-specific.

Source: NHS Employers / BMA medical pay scales (England). Indicative snapshot for the 2024/25 pay year — confirm current figures with NHS Employers (nhsemployers.org) and the BMA (bma.org.uk).

As of 2024/25, the NHS consultant pay scale in England ran from £105,504 to £139,882 — the same for a consultant clinical oncology as for any other specialty, because basic pay is set by grade, not by specialty.

£105,504–£139,882NHS consultant pay scale, England 2024/25 (indicative — grade-based, not specialty-based)
Foundation Year 1 (FY1)
£36,616
Specialty registrar (StR)
£55,329 – £70,425
Specialty doctor (SAS)
£59,175 – £95,400
Consultant
£105,504 – £139,882

+ 4 more not shown here. As of 2024/25 pay year (England). Source: NHS Employers / BMA medical pay scales (England).

Get the Clinical Oncology specialist-registration checklist

Enter your email and we send a step-by-step checklist for joining the GMC Specialist Register in clinical oncology — GMC registration, the Portfolio Pathway evidence mapped to the Royal College of Radiologists (RCR)'s curriculum, English evidence, and visa pointers. Free, no spam, unsubscribe anytime.

The GMC specialist-registration route in Clinical Oncology

  1. 1

    Hold GMC registration with a licence to practise

    Before anything specialty-specific, an internationally-qualified doctor must first be registered with the General Medical Council (GMC) with a licence to practise — usually via the PLAB examination or a GMC-recognised postgraduate qualification. The source-country routes are set out on our UK doctor pathway pages.

  2. 2

    Choose your specialist-registration route

    To take a substantive NHS consultant post you must join the GMC Specialist Register. There are two main routes: the CCT (Certificate of Completion of Training) for doctors who complete a UK training programme, and the Portfolio Pathway — the route the GMC introduced in late 2023 to replace CESR — for doctors whose training and experience were gained outside a UK programme.

  3. 3

    Map your evidence to the specialty curriculum

    The Portfolio Pathway is assessed against the UK curriculum for your specialty, which is set by the relevant Royal College or Faculty. You gather structured evidence — qualifications, logbooks, appraisals, assessments, reflective practice and testimonials — that demonstrates equivalence to a UK-trained specialist.

  4. 4

    Apply, be assessed, and join the Specialist (or GP) Register

    You submit your application to the GMC, which takes advice from the relevant Royal College or Faculty. If your evidence demonstrates the required standard, you are entered on the Specialist Register (or, for general practice, the GP Register) and become eligible for a substantive consultant or GP post. Confirm the current requirements and fees on gmc-uk.org.

Specialty-specific notes

Overseas clinical-oncology experience is evidenced against the RCR clinical-oncology curriculum through the Portfolio Pathway (formerly CESR). Recognised RCR examinations (FRCR in clinical oncology) can support GMC registration and specialist-register applications.

Because radiotherapy planning and systemic-therapy governance are tightly regulated, internationally-qualified oncologists commonly begin in a specialty-doctor (SAS) or trust-grade post, then map their evidence to the RCR curriculum for a Portfolio Pathway application.

CESR is now the Portfolio Pathway

If you trained outside a UK programme, this is the route you will use to join the GMC Specialist Register in this specialty. Here is what changed in late 2023, and what the evidence application involves.

For an internationally-qualified doctor, the phrase you will still see most often online is “CESR” — the Certificate of Eligibility for Specialist Registration (and CEGPR, its general-practice equivalent). CESR was the route by which a doctor who had not completed a UK training programme could still join the GMC Specialist Register or GP Register, by demonstrating that their training and experience were equivalent to a UK-trained specialist.

In late 2023 the General Medical Council replaced CESR and CEGPR with a single, renamed route: the Portfolio Pathway. The underlying principle is unchanged — you evidence equivalence to a UK Certificate of Completion of Training (CCT) — but the evidence framework was clarified and the application updated. Because the change is recent, most search results, forums and even some employer job adverts still say “CESR”; when they do, they are describing what is now the Portfolio Pathway.

The Portfolio Pathway is not an exam. It is a structured evidence application, assessed by the GMC with specialist advice from the relevant Royal College or Faculty against the UK curriculum for your specialty. There is no fixed processing time — each application is assessed individually — and a GMC fee applies. Being entered on the register is a licensing step, not a job offer.

For clinical oncology, the GMC takes specialist advice from the Royal College of Radiologists (RCR) against its UK curriculum — so the evidence you gather is mapped to that specialty's requirements.

From CESR to the Portfolio Pathway

  1. Before late 2023

    The route was called CESR (specialist register) or CEGPR (GP register). Doctors without a UK CCT applied by submitting evidence of equivalence to the relevant Royal College curriculum.

  2. Late 2023 (changes took effect from 30 November 2023)

    The GMC replaced CESR/CEGPR with the Portfolio Pathway — same equivalence principle, revised and clearer evidence requirements, and an updated application and fee. Existing CESR applications transitioned across.

  3. Now

    You apply through the Portfolio Pathway. The CCT route (completing a UK training programme) is unchanged and remains the alternative way onto the Specialist or GP Register.

What evidence the Portfolio Pathway looks for

The GMC assesses your application, with specialist advice from the relevant Royal College or Faculty, against the UK curriculum for your specialty. Evidence typically spans:

  • Primary medical qualification and postgraduate qualifications, verified by the GMC
  • A full, dated employment and appointment history with job descriptions
  • Clinical experience evidenced by logbooks, caseloads and outcome data where relevant
  • Workplace-based assessments, annual appraisals and multi-source (360°) feedback
  • Teaching, training and supervision of others
  • Audit, quality improvement and clinical governance activity
  • Research, publications and presentations, where you have them
  • Continuing professional development (CPD) records and reflective practice
  • Structured references and testimonials from senior colleagues

Important to understand

  • There is no guaranteed timescale — the Portfolio Pathway is assessed on the strength and completeness of your evidence, not on a fixed calendar.
  • A GMC application fee applies, and the amount is set by the GMC — confirm the current fee at gmc-uk.org.
  • The Royal College or Faculty for your specialty advises the GMC against its UK curriculum, so the evidence you gather is specialty-specific.
  • Joining the Specialist or GP Register makes you eligible for a substantive consultant or GP post. It is not itself a job, a visa, or a placement — you apply for posts separately and on your own account.

What you need, in summary

  • Hold GMC registration with a licence to practise (PLAB or a recognised postgraduate route)
  • For a consultant post, be on the GMC Specialist Register in clinical oncology (CCT or the Portfolio Pathway)
  • Evidence English-language proficiency by a route the GMC accepts
  • Hold the right to work in the UK (usually the Skilled Worker / Health and Care Worker visa, unless exempt)
  • Maintain appropriate professional indemnity and an up-to-date appraisal record

For your country-of-training route (PLAB, English evidence, visa), see the UK Doctor Pathway guide, which covers permitted source corridors only.

Frequently asked questions

What is the difference between clinical and medical oncology?+

In the UK, clinical oncologists are trained to deliver both radiotherapy and systemic (drug) therapy, while medical oncologists focus on systemic therapy. Both are on the GMC Specialist Register; clinical oncology sits under the Royal College of Radiologists. Confirm the current curriculum at rcr.ac.uk.

Does the FRCR help with GMC registration in oncology?+

Recognised Royal College of Radiologists examinations (FRCR in clinical oncology) can support GMC registration and a specialist-register application. The GMC confirms which qualifications support which route — check gmc-uk.org.

Is there really a 26% projected shortfall?+

The Royal College of Radiologists’ clinical oncology workforce census (2022 data, published 2023) reported a consultant shortfall of around 17% and projected it could reach roughly 26% by 2027 without action. Census figures are updated periodically — confirm the latest at rcr.ac.uk.

Does GeraClinic place oncologists into NHS jobs?+

No. GeraClinic is a telemedicine platform operated by Gera Systems Ltd, not a recruitment agency. This page is free educational information for doctors exploring the pathway independently; you apply directly, of your own accord, to the GMC and to any employer.

Important — please read

This is general information to help internationally-qualified doctors understand how UK specialist registration works for this specialty. It is not recruitment, immigration or legal advice. Gera is not a recruitment agency: we do not place doctors into NHS jobs, do not match candidates to specific vacancies, and do not actively recruit from countries on the WHO Health Workforce Support and Safeguards List (2023). You apply on your own account, directly to the GMC and to any employer. Registration routes, workforce figures, fees and pay scales change — always confirm the current position with the General Medical Council (gmc-uk.org), the relevant Royal College or Faculty, UK Visas and Immigration (gov.uk) and NHS Employers (nhsemployers.org).

Keep practising while you plan your move

GeraClinic is a remote telemedicine platform for licensed doctors. Wherever you are registered today, you can see patients online, set your own hours and fees, and keep earning while you work through your UK specialist registration. It is free to apply.